forked from Helmut01/replicateBE
-
Notifications
You must be signed in to change notification settings - Fork 0
/
DESCRIPTION
38 lines (38 loc) · 1.78 KB
/
DESCRIPTION
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
Encoding: UTF-8
Package: replicateBE
Version: 1.1.0
Date: 2021-06-21
Title: Average Bioequivalence with Expanding Limits (ABEL)
Authors@R: c(person(given = "Helmut",
family = "Schütz",
role = c("aut", "cre"),
email = "[email protected]",
comment = c(ORCID = "0000-0002-1167-7880")),
person(given = "Michael",
family = "Tomashevskiy",
role = "ctb",
email = "[email protected]"),
person(given = "Detlew",
family = "Labes",
role = "ctb",
email = "[email protected]",
comment = c(ORCID = "0000-0003-2169-426X")))
Author: Helmut Schütz [aut, cre] (<https://orcid.org/0000-0002-1167-7880>),
Michael Tomashevskiy [ctb],
Detlew Labes [ctb] (<https://orcid.org/0000-0003-2169-426X>)
Maintainer: Helmut Schütz <[email protected]>
Depends: R (>= 3.5.0)
Imports: readxl (>= 1.0.0), PowerTOST (>= 1.5.3), lmerTest, nlme,
pbkrtest, graphics, grDevices
Suggests: knitr, rmarkdown, testthat, devtools
Description: Performs comparative bioavailability calculations for Average Bioequivalence with
Expanding Limits (ABEL). Implemented are 'Method A' and 'Method B' and the detection of outliers.
If the design allows, assessment of the empiric Type I Error and iteratively adjusting alpha to
control the consumer risk.
Average Bioequivalence - optionally with a tighter (narrow therapeutic index drugs) or wider
acceptance range (Gulf Cooperation Council, South Africa: Cmax) - is implemented as well.
License: GPL (>=3)
LazyData: true
VignetteBuilder: knitr
URL: https://github.com/Helmut01/replicateBE
BugReports: https://github.com/Helmut01/replicateBE/issues